Long intergenic non-protein coding RNA 2849 (LINC02849)

LINC02849 (long intergenic non-protein coding RNA 2849) is a long non-coding RNA gene mapped to human chromosome 8 (8q21.3) and annotated by the HUGO Gene Nomenclature Committee (HGNC) and Ensembl, but there is no current evidence that it functions as a protein-coding gene, enzyme, receptor, transporter, or other classical therapeutic target type[7][8]. LINC02849 is classified as a long intergenic non-coding RNA (lincRNA), which are RNA transcripts longer than 200 nucleotides that do not code for proteins and are transcribed from regions between protein-coding genes[5][3][10]. While some lincRNAs have demonstrated regulatory roles in cell biology and disease, there are no published studies directly demonstrating the function, disease association, or therapeutic relevance of LINC02849. No information is available about drugs that interact with this RNA or its use as a biomarker. Its lack of biological or pathological annotation distinguishes it from more extensively studied lincRNAs (such as LINC00284/LINC00284), some of which have roles in cancer progression, gene regulation, or potential targeting strategies[1][5][3]. There is no indication that LINC02849 is currently studied or targeted in a therapeutic context.

Other names

LINC02849 (HGNC Symbol)ENSG00000285768 (Ensembl Gene ID)